BioCryst Pharmaceuticals Inc (BCRX) — Cash Flow Reinvestment Rate
BioCryst Pharmaceuticals Inc (BCRX) has a Cash Flow Reinvestment Rate of 0.28x as of December 2025, reinvesting $77.31 Million (capex $802.00K plus investments $-76.50 Million) from operating cash flow of $276.04 Million. Check BCRX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BioCryst Pharmaceuticals Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for BioCryst Pharmaceuticals Inc across 1 annual periods. Explore BCRX long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for BioCryst Pharmaceuticals Inc (2025–2025)
Year-by-year capital reinvestment analysis for BioCryst Pharmaceuticals Inc. For live market cap and broader valuation context, see BioCryst Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | $8.06 Million | $329.88 Million | $2.47 Million | — |